Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07039435 · ClinicalTrials.gov registry record · NA

Perceptual Adaptation Following Cochlear Implantation (Aim 3a)

A NA study of Sensorineural Hearing Loss and Cochlear Implantation, sponsored by NYU Langone Health.

Recruiting
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT07039435: Recruiting NA study of Sensorineural Hearing Loss and Cochlear Implantation, sponsored by NYU Langone Health.

NCT07039435 is a NA study of Sensorineural Hearing Loss and Cochlear Implantation that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 22 participants, below the 129-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07039435, a NA study of Sensorineural Hearing Loss and Cochlear Implantation, is actively recruiting participants, sponsored by NYU Langone Health.

RECRUITING
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to study the adaptation process in newly implanted Single-Sided Deaf Cochlear Implant (SSD-CI) users. Subjects will use four frequency maps for the first month after CI activation. One of these maps will be standard of care and the other three will have higher low frequency edges than the standard of care default maps. These maps will alternate daily during the first month (with exceptions made for situations when the subject is allowed to use a preferred map rather than the map predetermined for use that day), and after that point each subject will make a selection at the beginning of the week to compare all four maps and decide which one to use at the beginning of the following week. The goal of this study is to investigate how reducing place-pitch mismatch in SSD CI users affects 1) sound quality, 2) device use, and 3) speech perception.

Primary Outcome

The BKB-SIN speech-in-noise test measures speech perception in noise by assessing a listener's signal-to-noise ratio (SNR) loss. The test results are presented as the SNR loss, which is the amount the signal-to-noise ratio needs to be increased for the listener to correctly repeat 50% of the sentences. A higher SNR loss indicates more difficulty hearing.

Interventions

  • OTHER Alternative Frequency Mapping

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2024-01-04
Est. Completion 2029-07-31
Phase NA
NYU Langone Health

1,164 total trials

What NCT07039435 shows while recruiting

NCT07039435 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 129-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (83% lower).

The record links to 3 conditions, with Sensorineural Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which Alternative Frequency Mapping is the first listed.

NCT07039435 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT07039435 about?

NCT07039435 is a clinical study titled "Perceptual Adaptation Following Cochlear Implantation (Aim 3a)". The goal of this study is to study the adaptation process in newly implanted Single-Sided Deaf Cochlear Implant (SSD-CI) users. Subjects will use four frequency maps for the first month after CI activation. One of these maps will be standard of care and the other three will have higher low frequency...

What is the current status of trial NCT07039435?

This trial is currently recruiting. It is a NA study. The enrollment target is 22 participants. The study started on 2024-01-04. Estimated completion is 2029-07-31.

What conditions does trial NCT07039435 study?

This clinical trial studies the following conditions: Sensorineural Hearing Loss, Cochlear Implantation, Perceptual Adaptation.

What interventions are being tested in trial NCT07039435?

The interventions under investigation include: Alternative Frequency Mapping (OTHER).

Who is sponsoring clinical trial NCT07039435?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07039435 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sensorineural Hearing Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07039435's enrollment target sits among peer trials

22 11th of 13 higher than 3 of 13 other Sensorineural Hearing Loss trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sensorineural Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07039435, the US trial registry maintained by the National Library of Medicine. NCT07039435 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.